Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. drowsiness, nausea, vomiting) than with thiopental, methohexital, and etomidate. Propofol may be used prior to diagnostic procedures requiring anaesthesia, in the management of refractory status epilepticus, and for induction and/or maintenance of anaesthesia prior to and during surgeries.
Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus.
Clinique Ambroise Paré, Neuilly-sur-Seine, Hauts-de-Seine, France
Children's Health Children's Medical Center Dallas, Dallas, Texas, United States
Alder Hey Children's Hospital, Liverpool, Merseyside, United Kingdom
Hallym University Sacred Heart Hospital, Anyang-si, Dongan-gu, Korea, Republic of
Maimonides Medical Center, Brooklyn, New York, United States
Department of Anesthesiology and Pain Medicine, Severance Hospital, Yonsei University Health System, Seoul, Korea, Republic of
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.